Royal Bank of Canada’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-40,000
Closed -$207K 7533
2025
Q3
$207K Buy
+40,000
New +$230K ﹤0.01% 5085
2022
Q2
Sell
-1,839,400
Closed -$28.5M 7643
2022
Q1
$28.5M Buy
+1,839,400
New +$23.2M 0.01% 1026
2018
Q1
Sell
-128,500
Closed -$2.96M 6698
2017
Q4
$2.96M Buy
+128,500
New +$2.66M ﹤0.01% 2439
2017
Q2
Sell
-454,000
Closed -$11M 6718
2017
Q1
$11M Buy
+454,000
New +$12.2M 0.01% 1434

Other funds holding PTEN

Royal Bank of Canada's PTEN Position: Q1 2026 in Review

Royal Bank of Canada increased its Patterson-UTI (PTEN) stake by 12% in Q1 2026, buying an estimated $118K and bringing the position to 124,588 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #3397.

Royal Bank of Canada first reported a position in PTEN in Q2 2013 and has held it in 52 quarters since. The position peaked at $45.6M in Q1 2014. 412 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.

  • Royal Bank of Canada held 124,588 shares of Patterson-UTI worth $1.35M as of Q1 2026.
  • Royal Bank of Canada bought 13,790 Patterson-UTI shares in Q1 2026, an estimated $118K.
  • Patterson-UTI made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3397 holding.
  • Royal Bank of Canada first reported a position in Patterson-UTI in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Patterson-UTI position peaked at $45.6M in Q1 2014.
  • 412 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.